Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individuals

Journal of Infectious Diseases

Volumn 208, Issue 8, 2013, Pages 1240-1249

  Lucas, Gregory M ^a   Jing, Yuezhou ^a   Sulkowski, Mark ^a   Abraham, Alison G ^a   Estrella, Michelle M ^a   Atta, Mohamed G ^a   Fine, Derek M ^a   Klein, Marina B ^b   Silverberg, Michael J ^c   Gill, M John ^d   Moore, Richard D ^a   Gebo, Kelly A ^a   Sterling, Timothy R ^e   Butt, Adeel A ^f,g   Kirk, Gregory D ^h   Benson, Constance A ^h   Bosch, Ronald J ^h   Collier, Ann C ^h   Boswell, Stephen ^h   Grasso, Chris ^h   Mayer, Ken ^h   Hogg, Robert S ^h   Harrigan, Richard ^h   Montaner, Julio ^h   Cescon, Angela ^h   Brooks, John T ^h   Buchacz, Kate ^h   Carey, John T ^h   Rodriguez, Benigno ^h   Horberg, Michael A ^h   Thorne, Jennifer E ^h   Goedert, James J ^h   Jacobson, Lisa P ^h   Rourke, Sean B ^h   Burchell, Ann ^h   Rachlis, Anita R ^h   Rico, Puerto ^h   Hunter Mellado, Robert F ^h   Mayor, Angel M ^h   Deeks, Steven G ^h   Martin, Jeffrey N ^h   Patel, Pragna ^h   Saag, Michael S ^h   Mugavero, Michael J ^h   Willig, James ^h   Eron, Joseph J ^h   Napravnik, Sonia ^h   Kitahata, Mari M ^h   Crane, Heidi M ^h   Justice, Amy C ^h   Dubrow, Robert ^h   Fiellin, David ^h   Haas, David ^h   Bebawy, Sally ^h   Turner, Megan ^h   Gange, Stephen J ^h   Anastos, Kathryn ^h   McKaig, Rosemary G ^h   Freeman, Aimee M ^h   Lent, Carol ^h   Van Rompaey, Stephen E ^h   Webster, Eric ^h   Morton, Liz ^h   Simon, Brenda ^h   Althoff, Keri N ^h   Lau, Bryan ^h   Zhang, Jinbing ^h   Jing, Jerry ^h   Golub, Elizabeth ^h   Modur, Shari ^h   Hanna, David B ^h   Rebeiro, Peter ^h   Wong, Cherise ^h   Mendes, Adell ^h   more..

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c KAISER PERMANENTE   (United States)

^d UNIVERSITY OF CALGARY   (Canada)

^e VANDERBILT UNIVERSITY   (United States)

^f UNIVERSITY OF PITTSBURGH   (United States)

^g SHEIKH KHALIFA MEDICAL CITY   (United Arab Emirates)

^h NONE

Author keywords

chronic kidney disease; cohort study; glomerular filtration rate; hepatitis C RNA; hepatitis C virus; HIV; injection drug use

Indexed keywords

ATAZANAVIR; INDINAVIR; LOPINAVIR PLUS RITONAVIR; TENOFOVIR; VIRUS RNA;

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; RISK ASSESSMENT;

CHRONIC KIDNEY DISEASE; COHORT STUDY; GLOMERULAR FILTRATION RATE; HEPATITIS C RNA; HEPATITIS C VIRUS; HIV; INJECTION DRUG USE;

ADULT; CANADA; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; RNA, VIRAL; SUBSTANCE ABUSE, INTRAVENOUS; UNITED STATES; VIREMIA;

EID: 84885044184     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit373     Document Type: Article

References (35)

1. Alter MJ. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol 2006; 44:S6-9.
2. Butt AA, Wang X, Fried LF. HCV infection and the incidence of CKD. Am J Kidney Dis 2011; 57:396-402.
3. Tsui JI, Vittinghoff E, Shlipak MG, et al. Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease. Arch Intern Med 2007; 167:1271-6.
4. Wyatt CM, Malvestutto C, Coca SG, Klotman PE, Parikh CR. The impact of hepatitis C virus coinfection on HIV-related kidney disease: A systematic review and meta-analysis. AIDS 2008; 22:1799-807.
5. Jotwani V, Li Y, Grunfeld C, Choi AI, Shlipak MG. Risk factors for ESRD in HIV-infected individuals: Traditional and HIV-related factors. Am J Kidney Dis 2012; 59:628-35.
6. Tsui J, Vittinghoff E, Anastos K, et al. Hepatitis C seropositivity and kidney function decline among women with HIV: Data from the Women's Interagency HIV Study. Am J Kidney Dis 2009; 54:43-50.
7. George E, Nadkarni GN, Estrella MM, et al. The impact of hepatitis C coinfection on kidney disease related to human immunodeficiency virus (HIV): A biopsy study. Medicine (Baltimore) 2011; 90:289-95.
8. Cheng JT, Anderson HL Jr., Markowitz GS, Appel GB, Pogue VA, D'Agati VD. Hepatitis C virus-associated glomerular disease in patients with human immunodeficiency virus coinfection. J Am Soc Nephrol 1999; 10:1566-74.
9. Stokes MB, Chawla H, Brody RI, et al. Immune complex glomerulonephritis in patients coinfected with human immunodeficiency virus and hepatitis C virus. Am J Kidney Dis 1997; 29:514-25.
10. Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 2000; 133:592-9.
11. Brancati FL, Whelton PK, Randall BL, Neaton JD, Stamler J, Klag MJ. Risk of end-stage renal disease in diabetes mellitus: A prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial. JAMA 1997; 278:2069-74.
12. Fine DM, Garg N, Haas M, et al. Cocaine use and hypertensive renal changes in HIV-infected individuals. Clin J Am Soc Nephrol 2007; 2:1125-30.
13. Gitman MD, Singhal PC. Cocaine-induced renal disease. Expert Opin Drug Saf 2004; 3:441-8.
14. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Stamler J. End-stage renal disease in African-American and white men. 16-year MRFIT findings. JAMA 1997; 277:1293-8.
15. Martins D, Tareen N, Zadshir A, et al. The association of poverty with the prevalence of albuminuria: Data from the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis 2006; 47:965-71.
16. Micallef JM, Kaldor JM, Dore GJ. Spontaneous viral clearance following acute hepatitis C infection: A systematic review of longitudinal studies. J Viral Hepat 2006; 13:34-41.
17. Gange SJ, Kitahata MM, Saag MS, et al. Cohort Profile: The North American AIDS Cohort Collaboration on Research and Design (NAACCORD). Int J Epidemiol 2007; 36:294-301.
18. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150:604-12.
19. Levey AS, de Jong PE, Coresh J, et al. The definition, classification, and prognosis of chronic kidney disease: A KDIGO Controversies Conference report. Kidney Int 2011; 80:17-28.
20. Mocroft A, Neuhaus J, Peters L, et al. Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIVpositive, antiretroviral-treated adults. PLoS One 2012; 7:e40245.
21. Peters L, Grint D, Lundgren JD, et al. Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients. AIDS 2012; 26:1917-26.
22. Hagan H, Pouget ER, Des Jarlais DC, Lelutiu-Weinberger C. Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: The influence of time and place. Am J Epidemiol 2008; 168:1099-109.
23. Grebely J, Prins M, Hellard M, et al. Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: Towards a vaccine. Lancet Infect Dis 2012; 12:408-14.
24. Thomas DL, Thio CL, Martin MP, et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 2009; 461:798-801.
25. Jaffe JA, Kimmel PL. Chronic nephropathies of cocaine and heroin abuse: A critical review. Clin J Am Soc Nephrol 2006; 1:655-67.
26. Wilbert-Lampen U, Seliger C, Zilker T, Arendt RM. Cocaine increases the endothelial release of immunoreactive endothelin and its concentrations in human plasma and urine: Reversal by coincubation with sigma-receptor antagonists. Circulation 1998; 98:385-90.
27. Lai S, Fishman EK, Lai H, et al. Long-term cocaine use and antiretroviral therapy are associated with silent coronary artery disease in African Americans with HIV infection who have no cardiovascular symptoms. Clin Infect Dis 2008; 46:600-10.
28. Di Paolo N, Fineschi V, Di Paolo M, et al. Kidney vascular damage and cocaine. Clin Nephrol 1997; 47:298-303.
29. Sulkowski MS, Moore RD, Mehta SH, Chaisson RE, Thomas DL. Hepatitis C and progression of HIV disease. JAMA 2002; 288: 199-206.
30. Kalayjian RC, Lau B, Mechekano RN, et al. Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care. AIDS 2012; 26:1907-15.
31. Hendricks KM, Erzen HD, Wanke CA, Tang AM. Nutrition issues in the HIV-infected injection drug user: Findings from the nutrition for healthy living cohort. J Am Coll Nutr 2010; 29:136-43.
32. Lucas GM, Lau B, Atta MG, Fine DM, Keruly J, Moore RD. Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: A tale of two races. J Infect Dis 2008; 197:1548-57.
33. Choi AI, Rodriguez RA, Bacchetti P, Bertenthal D, Volberding PA, O'Hare AM. Racial differences in end-stage renal disease rates in HIV infection versus diabetes. J Am Soc Nephrol 2007; 18:2968-74.
34. Althoff KN, Buchacz K, Hall HI, et al. U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008. Ann Intern Med 2012; 157:325-35.
35. Mehta SH, Cox A, Hoover DR, et al. Protection against persistence of hepatitis C. Lancet 2002; 359:1478-83.